Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anemia
Hemoglobin raffimer used for severe anemia in Jehovah's Witness
June 13th, 2005
Investigators report the use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's Witness. In a recently published article, scientists in the United States and Canada conducted a study "to describe the successful treatment of acute, life-threatening anemia with the oxygen therapeutic agent, hemoglobin (Hb) raffimer. A 53-year-old female Jehovah's Witness developed severe anemia following total hip replacement. Due to prior patient directive, red blood cells were not transfused. Tachycardia, hypotension, electrocardiographic abnormalities, and mental status changes developed with a nadir Hb concentration of 3.2 g/dL." ...
Source: Health & Medicine Week (2005-06-13)
|
